DGS Capital Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$733K	Sell	52,937 -1,878	-3%	-$26.1K	0.12%	167
2025 Q4	$770K	Sell	54,815 -7,487	-12%	-$105K	0.13%	146
2025 Q3	$871K	Buy	62,302 +3,808	+7%	+$54.8K	0.16%	125
2025 Q2	$879K	Buy	58,494 +105	+0.2%	+$1.5K	0.18%	109
2025 Q1	$770K	Sell	58,389 -16,604	-22%	-$229K	0.2%	105
2024 Q4	$1.18M	Buy	74,993 +15,308	+26%	+$230K	0.3%	56
2024 Q3	$948K	Buy	59,685 +1,810	+3%	+$29.1K	0.26%	75
2024 Q2	$882K	Buy	57,875 +8,265	+17%	+$118K	0.25%	74
2024 Q1	$728K	Buy	49,610 +6,530	+15%	+$95.3K	0.21%	91
2023 Q4	$600K	Buy	43,080 +4,590	+12%	+$61.4K	0.23%	85
2023 Q3	$515K	Buy	38,490 +3,555	+10%	+$48.1K	0.25%	91
2023 Q2	$441K	Buy	34,935 +1,075	+3%	+$12.5K	0.22%	107
2023 Q1	$386K	Sell	33,860 -50	-0.1%	-$540	0.21%	104
2022 Q4	$351K	Buy	33,910 +1,910	+6%	+$20.6K	0.23%	110
2022 Q3	$335K	Buy	32,000 +1,640	+5%	+$17.5K	0.22%	102
2022 Q2	$336K	Buy	30,360 +8,680	+40%	+$94.4K	0.27%	88
2022 Q1	$242K	Buy	21,680 +3,665	+20%	+$41.6K	0.15%	152
2021 Q4	$236K	Buy	+18,015	New	+$227K	0.15%	132